APOA1 and atherosclerosis: Multivariate logistic regression analysis of the direct two-site apoA-I assay 110–525 for the presence of atherosclerosis (A) and obstructive CAD (B) in all the patients and separately for patients taking LLM (LLM users) and not taking LLM (non-LLM users).